Central Bank & Trust CO Novo Nordisk A S Transaction History
Central Bank & Trust CO
- $644 Million
- Q4 2024
A detailed history of Central Bank & Trust CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Central Bank & Trust CO holds 27,087 shares of NVO stock, worth $2.24 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
27,087
Previous 31,678
14.49%
Holding current value
$2.24 Million
Previous $3.77 Million
38.21%
% of portfolio
0.36%
Previous 0.53%
Shares
3 transactions
Others Institutions Holding NVO
# of Institutions
1,870Shares Held
318MCall Options Held
5.49MPut Options Held
7.77M-
Jennison Associates LLC19.9MShares$1.65 Billion1.06% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.19 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.18 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.1 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.01 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $186B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...